No Picture
Boston Cambridge Biotech Trending News

TriNetX Launches Prospective Patient Monitoring Platform Leveraging Global Real-World Data

TriNetX Follow the Patient enables the generation of real-world evidence for prospective monitoring studies CAMBRIDGE, Mass., May 13, 2022 /PRNewswire/ — TriNetX, LLC, the global network of healthcare organizations driving real-world research to accelerate the […]

No Picture
Boston Cambridge Biotech Trending News

Opinion: A consultant wrote the playbook on drug pricing — then distanced himself from it

When Biogen announced the price for Aduhelm, its controversial Alzheimer’s drug, the explanation the company gave — it represented the “overall value this treatment brings to patients, caregivers and society” — came right out of […]

No Picture
Boston Cambridge Biotech Trending News

Karyopharm Announces XPOVIO® (selinexor) Data to be Presented at the European Hematology Association 2022 Hybrid Congress

NEWTON, Mass., May 12, 2022 /PRNewswire/ — Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that initial data from a Phase 1 portion of the Ph 1/2 study […]

No Picture
Boston Cambridge Biotech Trending News

Moderna fires new CFO after one day

Moderna Inc.’s new chief financial officer is gone after about a day on the job, following a disclosure by his previous employer involving an internal financial investigation. Click here to view original post

No Picture
Boston Cambridge Biotech Trending News

Hologic Announces FDA Approval of Aptima® CMV Quant Assay for Human Cytomegalovirus

MARLBOROUGH, Mass.–(BUSINESS WIRE)– #Aptima–Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) approved its Aptima CMV Quant assay to quantify the viral load of cytomegalovirus (CMV) in patients who have […]